Dopamine Receptors D2 and D5 (D2, D5)

The term 'D2, D5' refers to two distinct G protein-coupled receptors: Dopamine receptor D2 (D2R) and Dopamine receptor D5 (D5R). D2R, encoded by the DRD2 gene, primarily inhibits adenylyl cyclase via Gi proteins and is a major target for antipsychotics. It is involved in motor control, cognition, and neuroendocrine signaling. D5R, encoded by the DRD5 gene and part of the D1-like dopamine receptor family, activates adenylyl cyclase and has high constitutive activity. It is mainly expressed in certain brain regions, including striatal cholinergic interneurons, and is involved in modulating motor function, cognition, and neurotrophic processes. Dysregulation of both receptors is linked to various psychiatric and neurodegenerative diseases. While often grouped in queries, they are separate molecular entities with distinct signaling pathways and pharmacological profiles.

Antagonists/partial agonists block dopamine binding to D2 receptors, treating psychosis and schizophrenia; Agonists mimic dopamine at D2 receptors to treat Parkinson's disease. D5 receptor agonists increase cAMP and downstream signaling, and D5 exhibits high constitutive activity. These distinct mechanisms contribute to diverse neurological functions and are involved in complex interplay within the dopamine system.